ERICA KETCHUM: Open Payments
NPI 1407308117 · MERRILLVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,128 in 61 payments from 23 companies in 2025. Trend: 2023 $1,882 · 2024 $1,547 · 2025 $1,128
Food & beverage: $1,128
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 18 | $265 |
| ABBVIE INC. | 11 | $232 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $108 |
| ARGENX US, INC. | 5 | $104 |
| PFIZER INC. | 2 | $40 |
| Lilly USA, LLC | 2 | $35 |
| Otsuka America Pharmaceutical, Inc. | 2 | $32 |
| Neurelis, Inc. | 1 | $29 |
| AstraZeneca Pharmaceuticals LP | 1 | $25 |
| ACADIA Pharmaceuticals Inc | 1 | $25 |
Products named: KESIMPTA, UBRELVY, QULIPTA, HYQVIA, VYVGART, NURTEC ODT, AMYVID, REXULTI.
Industry payments across IN — which companies pay providers there.
